Naturland Holding Zrt (BUD:NATURLAND) PE Ratio without NRI: 26.18 (As of Jun. 26, 2026) — Near Median


BUD:NATURLAND Naturland Holding Zrt BUD:NATURLAND
61 GF Score
Price Ft2,820.00
GF Value Ft2,879.22
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Naturland Holding Zrt PE Ratio without NRI?

Naturland Holding Zrt BUD:NATURLAND 61 PE Ratio without NRI is 26.18 as of Jun. 26, 2026, which is 5% above its 10-year median of 24.93. GuruFocus rates BUD:NATURLAND with a GF Score™ of 61/100 and a GF Value™ of Ft2,879.22 (Fairly Valued). The stock has 6 warning signs investors should review. Among 653 Drug Manufacturers companies, Naturland Holding Zrt ranks worse than 60.34% on this metric.

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2026-06-26), Naturland Holding Zrt's share price is Ft2820.00. Naturland Holding Zrt's EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2025 was Ft107.74. Therefore, Naturland Holding Zrt's PE Ratio without NRI for today is 26.18.

During the past 5 years, Naturland Holding Zrt's highest PE Ratio without NRI was 44.79. The lowest was 13.34. And the median was 24.93.

Naturland Holding Zrt's EPS without NRI for the six months ended in Jun. 2025 was Ft52.23. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2025 was Ft107.74.

As of today (2026-06-26), Naturland Holding Zrt's share price is Ft2820.00. Naturland Holding Zrt's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2025 was Ft105.93. Therefore, Naturland Holding Zrt's PE Ratio (TTM) for today is 26.62.

Warning Sign:

Naturland Holding Zrt stock PE Ratio (=27.43) is close to 3-year high of 29.53.

During the past years, Naturland Holding Zrt's highest PE Ratio (TTM) was 45.54. The lowest was 13.56. And the median was 25.29.

Naturland Holding Zrt's EPS (Diluted) for the six months ended in Jun. 2025 was Ft51.32. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2025 was Ft105.93.

Naturland Holding Zrt's EPS (Basic) for the six months ended in Jun. 2025 was Ft51.32. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2025 was Ft105.93.


Naturland Holding Zrt  (BUD:NATURLAND) PE Ratio without NRI Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio without NRI measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.


Naturland Holding Zrt PE Ratio without NRI Related Terms


Naturland Holding Zrt PE Ratio without NRI Historical Data

* Premium members only.

The historical data trend for Naturland Holding Zrt's PE Ratio without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Naturland Holding Zrt PE Ratio without NRI Chart

Naturland Holding Zrt Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
PE Ratio without NRI
N/A N/A 21.87 28.07 23.97

Naturland Holding Zrt Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
PE Ratio without NRI Get a 7-Day Free Trial Premium Member Only At Loss 28.07 At Loss 23.97 At Loss

BUD:NATURLAND vs ZTS, UTHR, VTRS: PE Ratio without NRI Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Naturland Holding Zrt's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Naturland Holding Zrt PE Ratio without NRI vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Naturland Holding Zrt's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Naturland Holding Zrt's PE Ratio without NRI falls into.


BUD:NATURLAND
61GF Score
Naturland Holding Zrt BUD:NATURLAND
PE Ratio without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Naturland Holding Zrt PE Ratio without NRI Calculation

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.

Naturland Holding Zrt's PE Ratio without NRI for today is calculated as

PE Ratio without NRI=Share Price/ EPS without NRI
=2820.00/107.735
=26.18

Naturland Holding Zrt's Share Price of today is Ft2820.00.
For company reported semi-annually, Naturland Holding Zrt's EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was Ft107.74.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months.

For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio without NRI →
What does a PE Ratio without NRI of 26.18 mean?
Naturland Holding Zrt (BUD:NATURLAND) has a PE Ratio without NRI of 26.18 as of Jun. 26, 2026. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Naturland Holding Zrt and its competitors. This is near median its historical median of 24.93. Over the past decade, Naturland Holding Zrt's PE Ratio without NRI has ranged from 13.34 to 44.79. According to the industry distribution chart, Naturland Holding Zrt ranks #394 out of 653 companies in the Drug Manufacturers industry, placing it in the top 60.3%.
Is Naturland Holding Zrt's PE Ratio without NRI too high?
Naturland Holding Zrt's current PE Ratio without NRI of 26.18 is near median its 10-year median of 24.93. Over the past 10 years, this metric has ranged from a low of 13.34 to a high of 44.79. The Drug Manufacturers industry median PE Ratio without NRI is 20.26. Naturland Holding Zrt's value of 26.18 is 29.2% above this industry median. Based on the distribution chart, Naturland Holding Zrt ranks #394 out of 653 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Naturland Holding Zrt has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Naturland Holding Zrt's PE Ratio without NRI compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Naturland Holding Zrt ranks #394 out of 653 companies for PE Ratio without NRI. This places Naturland Holding Zrt in the lower half of its industry. The industry median PE Ratio without NRI is 20.26. Naturland Holding Zrt's value of 26.18 is 29.2% above this benchmark. Historically, Naturland Holding Zrt's own PE Ratio without NRI has ranged from 13.34 to 44.79 over the past decade. While the company's 10-year median is 24.93 vs. the industry median of 20.26, Naturland Holding Zrt has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio without NRI for a Drug Manufacturers company?
The median PE Ratio without NRI among Drug Manufacturers companies is 20.26, based on 653 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio without NRI significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Naturland Holding Zrt's current PE Ratio without NRI of 26.18 is 29.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio without NRI mean?
A high PE Ratio without NRI can signal that a stock is expensive relative to its fundamentals. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Naturland Holding Zrt and its competitors. For the Drug Manufacturers industry, the median PE Ratio without NRI is 20.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Naturland Holding Zrt's current PE Ratio without NRI is 26.18, which is near median its own 10-year median of 24.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naturland Holding Zrt stock overvalued right now?
Based on GuruFocus' analysis, Naturland Holding Zrt (BUD:NATURLAND) is currently considered Fairly Valued. The stock's GF Value™ is Ft2,879.22, compared to a current price of Ft2,820.00 — trading 2.1% below its estimated fair value. The current PE Ratio without NRI is 26.18, which is near median its 10-year median of 24.93 and 29.2% above the Drug Manufacturers industry median of 20.26. Naturland Holding Zrt's overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio without NRI calculated?
PE Ratio without NRI is calculated from a company's financial statements. For Naturland Holding Zrt (BUD:NATURLAND), the current PE Ratio without NRI is 26.18 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Naturland Holding Zrt (BUD:NATURLAND) Overvalued in 2026?

Based on GuruFocus' analysis, Naturland Holding Zrt stock appears to be undervalued. The current stock price of Ft2,820.00 is trading 2.1% below its estimated GF Value™ of Ft2,879.22. GuruFocus considers Naturland Holding Zrt to be Fairly Valued.

Key valuation signals for BUD:NATURLAND:

  • PE Ratio without NRI: 26.18 (near median its 10-year median of 24.93)
  • GF Value™: Ft2,879.22 vs. price of Ft2,820.00 (2.1% below fair value)
  • GF Score™: 61/100 with 6 warning signs
  • Industry Position: 29.2% above the Drug Manufacturers median (#394 of 653)

No single metric tells the full story. See the BUD:NATURLAND stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Naturland Holding Zrt Business Description

Address Csillagvirag utca 8, Budapest, HUN, 1106
Naturland Holding Zrt thro9ugh its subsidiaries engage in the production of pharmaceutical products. It engages in the development, production, and wholesale of dietary supplements and cosmetics, herbal medicine, teas, and essential oils. The firm offers tablets, suppositories, ointments, and ophthalmic base solutions.
61GF Score

Get the complete analysis for BUD:NATURLAND

PE Ratio without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Ft2,820.00
Price
Ft2,879.22
GF Value